You are here

Sanofi

With help from Novartis and Sanofi, NeuroVia heads to the clinic armed with a $14M round

With help from Novartis and Sanofi, NeuroVia heads to the clinic armed with a $14M round

Endpoints

Flag link:

The flu vaccines are coming: GSK, Sanofi ship the first of more than 150M doses headed to U.S.

The flu vaccines are coming: GSK, Sanofi ship the first of more than 150M doses headed to U.S.

Fierce Pharma

Flag link:

Analyst: Payer hurdles hit dispense rates on Sanofi and Regeneron's eczema blockbuster-to-be Dupixent

Analyst: Payer hurdles hit dispense rates on Sanofi and Regeneron's eczema blockbuster-to-be Dupixent

Fierce Pharma

Flag link:

Sanofi gets a flu vaccines booster with $650M-plus Protein Sciences buy

Sanofi gets a flu vaccines booster with $650M-plus Protein Sciences buy

Fierce Pharma

Protein Sciences

Flag link:

Why Drugmakers Aren’t Sweating the Next Wave of Patent Losses

Why Drugmakers Aren’t Sweating the Next Wave of Patent Losses

Bloomberg

Flag link:

Rare-Disease Drugmakers Join in Worries Over GOP Health Overhaul

Rare-Disease Drugmakers Join in Worries Over GOP Health Overhaul

Bloomberg

healthcare reform

Jazz Pharmaceuticals

Vertex Pharmaceuticals

Flag link:

Sanofi and Alnylam plunge into PhIII with a rival to Roche’s top hemophilia drug

Sanofi and Alnylam plunge into PhIII with a rival to Roche’s top hemophilia drug

Endpoints

clinical trials

Flag link:

EuroBiotech Report: Brexit, BioNTech success, GlaxoSmithKline inks AI deal, Silence takes Alnylam to court and Shire makes cuts

EuroBiotech Report: Brexit, BioNTech success, GlaxoSmithKline inks AI deal, Silence takes Alnylam to court and Shire makes cuts

Fierce Biotech

artificial intelligence

Silence Therapeutics

Flag link:

Forget Sanofi's Zika shot. A new measure would limit pricing on all DOD-funded medication

Forget Sanofi's Zika shot. A new measure would limit pricing on all DOD-funded medication

Fierce Pharma

Department of Defense

Flag link:

Senators lay into Sanofi for Zika vaccine deal, call for public hearing

Senators lay into Sanofi for Zika vaccine deal, call for public hearing

Fierce Pharma

Flag link:

Regeneron’s Praluent May See Gradual Increase in 2017 Demand

Regeneron’s Praluent May See Gradual Increase in 2017 Demand

Market Realist

Flag link:

Sanofi: A Good Bet On Pharma

Sanofi: A Good Bet On Pharma

Seeking Alpha

Flag link:

Sanofi chief says U.S. Supreme Court ruling on biologics has "immediate impact"

Sanofi chief says U.S. Supreme Court ruling on biologics has "immediate impact"

Reuters

Olivier Brandicourt

Flag link:

Sanofi, Parexel collaborate on clinical trial data collection wearables

Sanofi, Parexel collaborate on clinical trial data collection wearables

Drug Delivery Business News

clinical trials

clinical trial data

Flag link:

Lexicon Pharma Goes Three For Three With Sotagliflozin Data

Lexicon Pharma Goes Three For Three With Sotagliflozin Data

Seeking Alpha

Lexicon Pharmaceuticals

type 1 diabetes

Flag link:

Sanofi, Gilead said to be eyeing potential $10B deal for prime cancer target Tesaro

Sanofi, Gilead said to be eyeing potential $10B deal for prime cancer target Tesaro

Fierce Pharma

Gilead Sciences

Flag link:

Sanofi and Regeneron's Praluent safely smacks LDL in high-risk diabetics

Sanofi and Regeneron's Praluent safely smacks LDL in high-risk diabetics

Fierce Pharma

LDL cholesterol

Flag link:

Novo's Xultophy beats basal-bolus insulin at cutting hypoglycemia, spurring weight loss

Novo's Xultophy beats basal-bolus insulin at cutting hypoglycemia, spurring weight loss

Fierce Pharma

Flag link:

ADA preview: 5 things to watch in diabetes

ADA preview: 5 things to watch in diabetes

BioPharma Dive

Boehringer Ingelheim

PCSK9 inhibitors

Amgen Regeneron

Flag link:

Pages